Hamilton, Canada

Beth Anne Adams

This inventor holds 1 USPTO granted patent. Top assignee: Vetoquinol S.a.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Beth Anne Adams

Introduction

Beth Anne Adams is a notable inventor based in Hamilton, Canada. She has made significant strides in the field of veterinary medicine, particularly in addressing behavioral issues in aging canines. Her work has the potential to improve the quality of life for many dogs and their owners.

Latest Patents

Beth Anne Adams holds a patent for the use of adrafinil to treat behavioral problems in aged canines. This innovative method involves administering adrafinil or a metabolite thereof to animals in need of such treatment. The patent highlights a novel approach to managing age-related behavioral problems in dogs, showcasing her commitment to enhancing animal welfare.

Career Highlights

Throughout her career, Beth has demonstrated a strong dedication to veterinary research and innovation. She is currently associated with Vetoquinol S.A., a company known for its focus on animal health. Her work at Vetoquinol has allowed her to collaborate with other professionals in the field, further advancing her research and contributions.

Collaborations

Beth Anne Adams has worked alongside notable colleagues such as William Norton Milgram and Christina Teresa Siwak. These collaborations have enriched her research and provided valuable insights into the challenges faced in veterinary medicine.

Conclusion

Beth Anne Adams is a pioneering inventor whose work in treating behavioral problems in aging dogs is making a significant impact. Her innovative approach and dedication to animal health continue to inspire advancements in veterinary care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…